Prevalence of Hepatitis C Virus Antibodies Among Blood Donors in Northern Jordan(Brief Communications )

作者: Khaled Jadallah , Ismail Matalka , Abdullah Rashdan , Shadi Hijjawi

DOI:

关键词:

摘要: Background and Objectives: Hepatitis C Virus (HCV) remains the most common cause of transfusion-related hepatitis in world. Despite accurate screening methods introduced after discovery virus about two decades ago, blood products transfusion an important source HCV infection Jordan. The worldwide prevalence among donors is variable, ranging between 0.17 20%. main objective this study was to determine positive serology for population Northern different genotypes individuals a secondary study. Study Population Methods: From January 2004 till June 2006, total 14,236 (13666 males 570 females) donated at King Abdullah University Hospital. A third-generation Enzyme- Linked Immuno-Sorbent Assay (ELISA) test system using commercial Diasorin kit, ETI-AB-HCVK- 4(N0146, N0147) which used screen all antibodies HCV. performed strictly as per manufacturer's instructions. Data were collected from bank database. Samples detectable RNA submitted genotyping Real Time PCR. (MX 4000) method. Results: 29 (27 males, 2 tested anti-HCV antibodies, with overall 0.20%. seroprevalence females approximately double that (0.35% vs 0.19%). prevalent genotype type 4. Conclusion: This indicates North Jordan lower than other regions country. Overall, our national healthy (0.2%-0.79%) concordant results epidemiological studies Western World (0.17-0.1.5%). cohort 4.

参考文章(17)
N. K. D. Halim, O. I. Ajayi, Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria. East African Medical Journal. ,vol. 77, pp. 410- 412 ,(2000)
GIUSEPPE MONTALTO, MELCHIORRE CERVELLO, LYDIA GIANNITRAPANI, FABIO DANTONA, ANGELA TERRANOVA, LUIGI A. M. CASTAGNETTA, Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Annals of the New York Academy of Sciences. ,vol. 963, pp. 13- 20 ,(2006) , 10.1111/J.1749-6632.2002.TB04090.X
P. Kuhnl, S. Seidl, W. Stangel, J. Beyer, W. Sibrowski, J. Flik, ANTIBODY TO HEPATITIS C VIRUS IN GERMAN BLOOD DONORS The Lancet. ,vol. 334, pp. 324- ,(1989) , 10.1016/S0140-6736(89)90500-X
C. Janot, A.M. Couroucé, M. Maniez, ANTIBODIES TO HEPATITIS C VIRUS IN FRENCH BLOOD DONORS The Lancet. ,vol. 334, pp. 796- 797 ,(1989) , 10.1016/S0140-6736(89)90851-9
Gilles Delage, Claire Infante–Rivard, Jo–Anne Chiavetta, Bernard Willems, David Pi, Margaret Fast, Risk Factors for Acquisition of Hepatitis C Virus Infection in Blood Donors: Results of a Case-Control Study Gastroenterology. ,vol. 116, pp. 893- 899 ,(1999) , 10.1016/S0016-5085(99)70072-7
D. Bresters, H. T. M. Cuypers, H.W. Reesink, W. P. Schaasberg, C. L. Poet, E. P. Mauser-Bunschoten, M. Houghton, Q.-L. Choo, G. Kuo, R. Lesniewski, H. Troonen, P. N. Lelie, Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sanguinis. ,vol. 62, pp. 213- 217 ,(1992) , 10.1111/J.1423-0410.1992.TB01201.X
Annemarie Wasley, Miriam J. Alter, Epidemiology of hepatitis C: geographic differences and temporal trends. Seminars in Liver Disease. ,vol. 20, pp. 1- 16 ,(2000) , 10.1055/S-2000-9506
G. Sirchia, A. Bellobuono, A. Giovanetti, M. Marconi, Antibodies to hepatitis C virus in Italian blood donors. The Lancet. ,vol. 334, pp. 797- ,(1989) , 10.1016/S0140-6736(89)90852-0
Fuad Hasan, Lennox J. Jeffers, Maria De Medina, K. Rajender Reddy, Talley Parker, Eugene R. Schiff, Michael Houghton, Quilim Choo, George Kuo, Hepatitis C–associated hepatocellular carcinoma Hepatology. ,vol. 12, pp. 589- 591 ,(1990) , 10.1002/HEP.1840120323